IGAM
AZN icon

iA Global Asset Management’s AstraZeneca AZN Stock Holding History

iA Global Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,293
Closed -$10.9M – 406
2025
Q4 		$10.9M Buy
59,293
+2,198
+4% +$385K 0.14% 128
2025
Q3 		$8.76M Buy
57,095
+2,808
+5% +$425K 0.12% 136
2025
Q2 		$7.59M Sell
54,287
-20,147
-27% -$2.82M 0.11% 140
2025
Q1 		$10.9M Buy
74,434
+357
+0.5% +$51.7K 0.19% 100
2024
Q4 		$9.71M Buy
74,077
+3,457
+5% +$484K 0.17% 103
2024
Q3 		$11M Buy
70,620
+42,018
+147% +$6.78M 0.19% 91
2024
Q2 		$4.46M Buy
28,602
+1,245
+5% +$187K 0.09% 160
2024
Q1 		$3.71M Buy
27,357
+1,171
+4% +$155K 0.08% 180
2023
Q4 		$3.53M Buy
26,186
+1,907
+8% +$248K 0.08% 181
2023
Q3 		$3.29M Buy
24,279
+6,027
+33% +$823K 0.09% 177
2023
Q2 		$2.61M Buy
+18,252
New +$2.69M 0.07% 205

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

iA Global Asset Management's AZN Position: Q1 2026 in Review

iA Global Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 59,293 shares — an estimated $10.9M sold.

iA Global Asset Management first reported a position in AZN in Q2 2023 and held it in 11 quarters. The position peaked at $11M in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • iA Global Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • iA Global Asset Management sold 59,293 AstraZeneca shares in Q1 2026, an estimated $10.9M.
  • iA Global Asset Management first reported a position in AstraZeneca in Q2 2023 and held it in 11 quarters.
  • iA Global Asset Management's AstraZeneca position peaked at $11M in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on iA Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.